Choix d’assurance complémentaire tenant compte de la rationalité limitée des assurés Jessica LAUBERT2023-03-23T11:25:06+01:0016/02/2023| Lire la suite
Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes? Jessica LAUBERT2023-01-24T18:01:40+01:0019/01/2023| Lire la suite
Determinants of the cost-effectiveness of telemedicine: systematic screening and quantitative analysis of the literature Jessica LAUBERT2023-09-07T15:02:16+01:0001/01/2023| Lire la suite
Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes? Jessica LAUBERT2022-12-28T10:48:48+01:0022/10/2022| Lire la suite
